ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,629 companies indexed · Last updated: today
DirectoryBusiness & Technical ServicesResearch & DevelopmentBedanoOsmopharm SA
Osmopharm SA Logo
Verified· 2 sourcesTrust Score
Summary

About the company

The core activity of Osmopharm SA is the development and production of modified oral dosage forms, particularly in pellet, tablet or resin form, using advanced galenic technologies such as coating, extrusion-spheronization and ion exchange. The company also offers services such as the manufacture of hard gelatin capsules or tablets, capsule filling and packaging of pharmaceuticals. Additionally, Osmopharm supports its customers in preparing registration applications and conducting regulatory activities.

AI-generated
Offering

Products & services

Industry:Research & DevelopmentPharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

Osmopharm SA

✓ Offered7
Modified release oral dosage forms
Modified release systems for oral drugs, including pellets, sustained release tablets and modified release products based on advanced galenic technologies.
Contract manufacturing
Bulk manufacturing, capsules filling, tabletting, blistering, bottles filling and final consumer packaging for pharmaceutical products.
R&D studies and development support
R&D studies, analytical and production validations, products stability studies and technical dossier preparation in CTD format.
Pellets
Pellet dosage forms in coating-pan or extrusion-spheronisation technology, suitable for capsule filling or direct compression into sustained release tablets.
Ion-exchange resinates
Ion-exchange resinates and taste-masked syrups for modified release forms, including suspension in syrup and release after ingestion in gastric acid.
Blistering and packaging
Blistering, putting in flasks and packaging in cases as part of the production line for finished pharmaceutical products.
Pharmaceutical product portfolio
Pharmaceuticals, pharmaceutical associations and food in the dosages and forms most required by customers, developed as part of the company product list.
Trust & reputation

ranQ Trust Score of Osmopharm SA: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 54% · As of October 2026

Without public customer reviews the score stays capped.

Osmopharm SA has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
Osmopharm SA scores 85.5 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.100.012%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.55.07%
Osmopharm SA scores 83.3 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).83.322%
Osmopharm SA scores 13.7 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.13.74%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

Osmopharm SA reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once Osmopharm SA has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Osmopharm SA in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Osmopharm SA by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Osmopharm SA to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Via alle Fornaci
6930 Bedano

At a glance

Legal form
Corporation
UID
CHE-101.622.972
Founded
1994 · 32 years
Last commercial register change
April 28, 2020
Employees
1 to 10
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    AP
    Alpex Pharma SA
    Mezzovico
    ES
    EVOBIOTIX SA
    Melide
    NP
    NOVELTY PHARMA GALENICAL DEVELOPMENT AND DOCUMENTATION SA
    Cadempino
    FS
    Fordras SA
    Lugano
    CI
    CEBIS INTERNATIONAL SAGL
    Balerna
    FS
    FEMTOprint SA
    Agno
    CS
    CHELONIA SA
    Lugano
    FS
    Ficufish Sagl
    Corteglia